This bulletin reviews the place in therapy of rosuvastatin in relation to other statins.
In 2017 we amended the bulletin as a subscriber pointed out we still had an aspect of the old NICE guidance in there where diabetes was classed as secondary prevention. As per NICE CG181, both type 1 and type 2 diabetes fit under primary prevention where specific criteria are met.
